{
  "name": "Life Science Vendor Index Guides",
  "as_of": "2026-07-14",
  "count": 4,
  "guides": [
    {
      "slug": "clinical-research-organization-buyer-guide",
      "name": "How to Choose a Clinical Research Organization (CRO): A Buyer's Guide",
      "category": "cro",
      "url": "https://lifesciencevendorindex.com/guides/clinical-research-organization-buyer-guide",
      "primary_keyword": "clinical research organization",
      "search_volume": 1100,
      "aka": [
        "CRO selection guide",
        "CRO vendor selection"
      ],
      "methods": [
        "Protocol design and biostatistical planning",
        "Site identification, feasibility, and activation",
        "Patient recruitment and retention support",
        "Clinical monitoring (on-site and remote/risk-based)",
        "Clinical data management and database lock",
        "Regulatory submission support (IND/CTA, NDA/BLA)",
        "Pharmacovigilance and safety signal monitoring",
        "Medical writing and clinical study reports"
      ],
      "standards_bodies": [
        {
          "name": "U.S. Food and Drug Administration",
          "abbr": "FDA",
          "note": "The U.S. regulator that reviews IND applications and inspects trial conduct for GCP compliance under 21 CFR Parts 50, 54, 56, and 312."
        },
        {
          "name": "International Council for Harmonisation Good Clinical Practice",
          "abbr": "ICH-GCP (E6)",
          "note": "The internationally recognized ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials that most CROs are contractually required to follow."
        },
        {
          "name": "European Medicines Agency",
          "abbr": "EMA",
          "note": "The EU regulator that reviews clinical trial applications (CTAs) and inspects trial conduct across EU member states."
        }
      ]
    },
    {
      "slug": "cdmo-cmo-selection-guide-pharma",
      "name": "Contract Manufacturing Organization (CDMO/CMO) Selection Guide for Pharma",
      "category": "cdmo",
      "url": "https://lifesciencevendorindex.com/guides/cdmo-cmo-selection-guide-pharma",
      "primary_keyword": "contract manufacturing organization pharma",
      "search_volume": 200,
      "aka": [
        "CDMO selection",
        "CDMO vs CMO"
      ],
      "methods": [
        "Process development and formulation",
        "Analytical method development and validation",
        "cGMP drug substance manufacturing",
        "cGMP drug product / fill-finish manufacturing",
        "Scale-up and technology transfer",
        "Clinical trial and commercial packaging"
      ],
      "standards_bodies": [
        {
          "name": "U.S. Food and Drug Administration",
          "abbr": "FDA",
          "note": "Inspects drug manufacturing facilities for compliance with Current Good Manufacturing Practice (cGMP) regulations under 21 CFR Parts 210 and 211."
        },
        {
          "name": "European Medicines Agency GMP framework",
          "abbr": "EU GMP",
          "note": "Coordinates GMP inspections of manufacturing sites supplying the EU market under EudraLex Volume 4."
        },
        {
          "name": "International Council for Harmonisation Q7",
          "abbr": "ICH Q7",
          "note": "The internationally harmonized GMP guideline specifically for active pharmaceutical ingredient (API) manufacturing."
        }
      ]
    },
    {
      "slug": "biostatistics-consulting-buyer-guide",
      "name": "How to Hire a Biostatistics Consulting Firm: What to Evaluate",
      "category": "regulatory-biostatistics",
      "url": "https://lifesciencevendorindex.com/guides/biostatistics-consulting-buyer-guide",
      "primary_keyword": "biostatistics consulting",
      "search_volume": 80,
      "aka": [
        "Biostatistics consulting",
        "Regulatory affairs consultant pharma"
      ],
      "methods": [
        "Statistical analysis plan (SAP) development",
        "Sample size and power calculations",
        "Adaptive and Bayesian trial design",
        "Interim analysis and Data Monitoring Committee support",
        "Regulatory statistical submission packages (FDA/EMA)",
        "Regulatory strategy and agency-meeting preparation"
      ],
      "standards_bodies": [
        {
          "name": "U.S. Food and Drug Administration",
          "abbr": "FDA",
          "note": "Reviews statistical analysis plans and submission packages as part of IND, NDA, and BLA review."
        },
        {
          "name": "International Council for Harmonisation E9",
          "abbr": "ICH E9",
          "note": "The internationally harmonized guideline on statistical principles for clinical trials that most regulatory-grade statistical work is built against."
        },
        {
          "name": "European Medicines Agency",
          "abbr": "EMA",
          "note": "Reviews statistical methodology as part of clinical trial and marketing authorization applications in the EU."
        }
      ]
    },
    {
      "slug": "clinical-data-management-vendor-guide",
      "name": "Clinical Data Management (CDM) Vendor Selection Guide",
      "category": "eclinical-data",
      "url": "https://lifesciencevendorindex.com/guides/clinical-data-management-vendor-guide",
      "primary_keyword": "clinical data management vendor",
      "search_volume": 80,
      "aka": [
        "EDC vendor selection",
        "eClinical technology vendor"
      ],
      "methods": [
        "Electronic data capture (EDC) study build",
        "Randomization and trial supply management (IRT/RTSM)",
        "Electronic clinical outcome assessment (eCOA/ePRO)",
        "eConsent and remote patient engagement tools",
        "Data cleaning, query management, and database lock",
        "System validation and 21 CFR Part 11 documentation"
      ],
      "standards_bodies": [
        {
          "name": "U.S. Food and Drug Administration electronic records rule",
          "abbr": "FDA / 21 CFR Part 11",
          "note": "The FDA regulation governing electronic records and electronic signatures used in regulated clinical trial data systems."
        },
        {
          "name": "International Council for Harmonisation E6(R2)",
          "abbr": "ICH E6(R2)",
          "note": "The Good Clinical Practice addendum that sets expectations for computerized systems and data integrity in modern, often decentralized, clinical trials."
        }
      ]
    }
  ]
}